These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combination antifungal therapy: a critical review of the evidence. Ostrosky-Zeichner L Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131 [TBL] [Abstract][Full Text] [Related]
5. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy. Rogers TR; Frost S Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371 [TBL] [Abstract][Full Text] [Related]
6. Decision making in antifungal monotherapy versus combination therapy. Lewis RE Pharmacotherapy; 2006 Jun; 26(6 Pt 2):61S-67S. PubMed ID: 16716124 [TBL] [Abstract][Full Text] [Related]
7. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? Muñoz P; Singh N; Bouza E Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385 [TBL] [Abstract][Full Text] [Related]
8. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing? Vazquez JA Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092 [TBL] [Abstract][Full Text] [Related]
9. Design of efficacy trials of cytokines in combination with antifungal drugs. Kullberg BJ; Oude Lashof AM; Netea MG Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in antifungal chemotherapy. Petrikkos G; Skiada A Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625 [TBL] [Abstract][Full Text] [Related]
11. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. Metcalf SC; Dockrell DH J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716 [TBL] [Abstract][Full Text] [Related]
12. Is there a role for polyenes in treating invasive mycoses? Cornely OA; Vehreschild JJ; Ullmann AJ Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332 [TBL] [Abstract][Full Text] [Related]
13. Toward more effective antifungal therapy: the prospects of combination therapy. Kontoyiannis DP; Lewis RE Br J Haematol; 2004 Jul; 126(2):165-75. PubMed ID: 15238137 [TBL] [Abstract][Full Text] [Related]
14. Recent trends in antifungal therapy: focus on systemic mycoses. Ray A; Anand S Indian J Chest Dis Allied Sci; 2000; 42(4):357-66. PubMed ID: 15597685 [TBL] [Abstract][Full Text] [Related]
15. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine. Chamilos G; Kontoyiannis DP Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387 [TBL] [Abstract][Full Text] [Related]
16. Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients? Leather HL; Wingard JR Curr Opin Infect Dis; 2006 Aug; 19(4):371-9. PubMed ID: 16804386 [TBL] [Abstract][Full Text] [Related]
17. Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data. Muñoz P; Guinea J; Narbona MT; Bouza E Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S125-31. PubMed ID: 19013336 [TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM; Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037 [TBL] [Abstract][Full Text] [Related]
20. Candida endophthalmitis: focus on current and future antifungal treatment options. Khan FA; Slain D; Khakoo RA Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]